Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA clears Zoll's IBP (invasive blood pressure)/TEMP (temperature) defibrillator:

This article was originally published in Clinica

Executive Summary

Zoll Medical has received US FDA 510(k) marketing clearance for its M Series defibrillators with features for invasive blood pressure (IBP) and temperature (TEMP) monitoring. "The addition of IBP and TEMP positions the M Series as the most compact and lightest integrated transport defibrillator," claims Michael Parascandola, a marketing director at the Burlington, Massachusetts firm.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT072407

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel